.Attribute Medication, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Perspective asks for introduction of individuals with MASLD as well as size of liver end results in cardio-- kidney-- metabolic tests, when information advise mechanistically plausible advantages and clinical security-- and summarizes considerations for trial style and also regulative commendation.